Document is current
Any future updates will be listed below
-
Authors
- License Information
-
More Information
Article History
Received: 30 January 2020
Revised: 4 June 2020
Accepted: 16 June 2020
First Online: 2 July 2020
Compliance with ethical standards
:
: HM and AS are inventors of intellectual property related to the usage of Neuregulin 1 as therapeutic approach. D-LH declares no competing financial interests.
